Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVIDIM: Immune Response to COVID-19 Vaccines in Hospital Staff
NCT04896788Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- May 2021
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Open-label trial in coronavirus disease 2019 (COVID-19), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Blood level of anti-S1 / RBD antibodies at 24 months. Status: unknown.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04896788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04896788.